A phase 2 study from Spiera et al. found that patients with glucocorticoid-dependent PMR taking the antibody-drug conjugate ABBV-154 had a longer time to flare compared with those taking placebo, supporting further investigation.
New Discoveries in Sjögren’s Disease
Although dryness and other symptoms of Sjögren’s disease continue to vex patients, the prospect of new treatments and a recent name change demonstrate advances in patient care.
Ethical Concerns in Rheumatology Require Nuance
Patient autonomy in healthcare decisions and physician conflicts of interest are just two areas of ethical concerns that arise frequently in rheumatology. Dr. Kelly Weselman discusses ethical dilemmas and how to address them.
How to Recognize Inborn Errors of Immunity
Inborn errors of immunity may not always be easy to recognize, but rheumatologists should look out for them. Dr. Bharat Kumar shares his insights.
My Six Cents: How to Help a Patient Feel Seen & Heard
Compassion, clear communication, empathy and more—Samantha C. Shapiro, MD, provides practical advice on how to connect with your patients during appointments.
In the Details: Diagnosing PsA Requires Drilling Down
Rheumatologists must do some detective work into a patient’s signs and symptoms when considering a psoriatic arthritis diagnosis, according to Philip J. Mease, MD, MACR
Strong Argument: Recent Developments in Myositis Diagnosis & Care
Lisa Christopher-Stine, MD, MPH, discussed the latest findings on myositis and its subtypes, including insights into antibodies linked to cancer and treatments for these patients.
The Great Imitator: Updates on Sarcoidosis
Michelle Sharp, MD, MHS, shared insights into the complexities of sarcoidosis, describing how she evaluates, diagnoses and treats patients.
Initiative Trains Clinicians About RA for the Navajo Community
The Rheumatology Access Expansion Initiative helps meet the needs of patients with rheumatoid arthritis in an underserved community in the U.S.
Should We Manage Men & Women Differently?
Experts address how sex differences affect the clinical presentation, diagnosis, response to therapy and experience of illness for patients with PsA.
- 1
- 2
- 3
- …
- 87
- Next Page »